Understanding the financial cost of cancer clinical trial participation.
Courtney P WilliamsLuqin DengNicole E CastonKathleen D GallagherRebekah AngoveMaria PisuAndres AzueroRebecca ArendGabrielle Betty RocquePublished in: Cancer medicine (2024)
Cancer clinical trial-related financial hardship, most often stemming from travel expenses, affected almost half of trial-enrolled patients. Interventions are needed to reduce adverse financial participation effects and potentially improve cancer clinical trial participation.
Keyphrases
- clinical trial
- papillary thyroid
- physical activity
- phase ii
- childhood cancer
- study protocol
- squamous cell
- phase iii
- end stage renal disease
- open label
- chronic kidney disease
- double blind
- ejection fraction
- randomized controlled trial
- squamous cell carcinoma
- patient reported outcomes
- patient reported
- health insurance
- drug induced